The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease

Medicine and Dentistry

• Combination Therapy 100%
• Drug Megadose 83%
• Hodgkin's Lymphoma 83%
• Patient 66%
• Diseases 50%
• High Dose Chemotherapy 33%
• Conditioning 33%
• Experience 33%
• Bone Marrow 33%
• Neoplasm 16%
• Spontaneous Remission 16%
• Chemoradiotherapy 16%
• Toxicity 16%
• Infusion 16%
• Tumor Cell 16%
• ABVD 16%
• Supportive Care 16%
• Inpatient 16%
• Therapeutic Procedure 16%
• Relapse 16%

INIS

• therapy 100%
• doses 100%
• patients 83%
• hodgkins disease 83%
• diseases 50%
• toxicity 33%
• bone marrow 33%
• chemotherapy 33%
• tumors 16%
• tumor cells 16%
• performance 16%
• failures 16%
• refractories 16%
• infusion 16%
• combined therapy 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Hodgkin Disease 83%
• Diseases 50%
• Chemotherapy 33%
• Toxicity 16%
• Neoplasm 16%
• Remission 16%
• Relapse 16%